Arkema (OTCMKTS:ARKAY) Stock Rating Upgraded by Barclays

Arkema (OTCMKTS:ARKAY – Get Free Report) was upgraded by Barclays from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

A number of other research firms have also recently weighed in on ARKAY. Zacks Research raised shares of Arkema from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Berenberg Bank cut Arkema from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. The Goldman Sachs Group downgraded Arkema from a “buy” rating to a “neutral” rating in a report on Monday, June 8th. Sanford C. Bernstein upgraded Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Kepler Capital Markets cut Arkema from a “hold” rating to a “strong sell” rating in a report on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Get Arkema alerts:

View Our Latest Stock Analysis on Arkema

Arkema Stock Performance

ARKAY opened at $71.81 on Wednesday. The company’s 50 day moving average is $65.99 and its 200-day moving average is $67.92. Arkema has a 1-year low of $56.28 and a 1-year high of $79.36. The company has a current ratio of 2.25, a quick ratio of 1.64 and a debt-to-equity ratio of 0.53. The company has a market cap of $5.46 billion, a P/E ratio of 247.62 and a beta of 0.85.

Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.12. The business had revenue of $2.79 billion during the quarter, compared to analysts’ expectations of $2.86 billion. Arkema had a net margin of 0.67% and a return on equity of 4.27%. Equities research analysts predict that Arkema will post 3.67 earnings per share for the current fiscal year.

Arkema Company Profile

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

Recommended Stories

• Five stocks we like better than Arkema
• Asian Market Circuit Breakers Hit Stocks, Not AI Demand
• Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
• Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
• Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal

Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.